Cargando…
Uncharted territories in the discovery of antifungal and antivirulence natural products from bacteria
Many fungi can cause deadly diseases in humans, and nearly every human will suffer from some kind of fungal infection in their lives. Only few antifungals are available, and some of these fail to treat intrinsically resistant species and the ever-increasing number of fungal strains that have acquire...
Autores principales: | Vij, Raghav, Hube, Bernhard, Brunke, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905183/ https://www.ncbi.nlm.nih.gov/pubmed/33680363 http://dx.doi.org/10.1016/j.csbj.2021.02.003 |
Ejemplares similares
-
S9.3d Antivirulence drug discovery to disarm Candida albicans with metabolites from myxobacteria.
por: Vij, Raghav, et al.
Publicado: (2022) -
Antivirulence and avirulence genes in human pathogenic fungi
por: Siscar-Lewin, Sofía, et al.
Publicado: (2019) -
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
por: Porcari, Aldostefano, et al.
Publicado: (2020) -
Obesogens in Children—An Uncharted Territory
por: Močnik, Mirjam, et al.
Publicado: (2021) -
P003 Synthetic antifungal peptide mimic kills Candida albicans by targeting protein glycosylation and synergistically prevents infection
por: Schaefer, Sebastian, et al.
Publicado: (2022)